Stay updated on Nivolumab and Metformin in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Metformin in Lung Cancer Clinical Trial page.

Latest updates to the Nivolumab and Metformin in Lung Cancer Clinical Trial page
- Check6 days agoChange DetectedThe clinical trial record for nivolumab and metformin in advanced non-small cell lung cancer is now displayed, with study design, participation criteria, outcome measures, and record history.SummaryDifference63%

- Check13 days agoChange DetectedThe footer revision label changed from `v3.7.2` to `v3.8.0`.SummaryDifference0.2%

- Check20 days agoChange DetectedA site-wide NIH announcement about using “Super Intelligence” in place of “Artificial Intelligence” appears above the ClinicalTrials.gov error page.SummaryDifference1%

- Check27 days agoChange DetectedThe ClinicalTrials.gov error page footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check34 days agoChange DetectedThe footer revision changed from v3.7.0 to v3.7.1 while the page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record content, indicating the page is not accessible and shows the standard error screen.SummaryDifference21%

Stay in the know with updates to Nivolumab and Metformin in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Metformin in Lung Cancer Clinical Trial page.